📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Repair of acute respiratory distress syndrome by stromal cell administration (REALIST) trial: A phase 1 trial. (2021)

First Author: Gorman E

Attributed to: Mesenchymal Stem Cell (MSC) regulation of pulmonary macrophage populations in Acute Respiratory Distress Syndrome (ARDS). funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.eclinm.2021.101167

PubMed Identifier: 34746723

Publication URI: http://europepmc.org/abstract/MED/34746723

Type: Journal Article/Review

Volume: 41

Parent Publication: EClinicalMedicine

ISSN: 2589-5370